Ulteriori informazioni
Cardiovascular biomarkers are necessary diagnostic tools used in the clinical practices of cardiology. They are useful for the purpose of diagnosis, prognosis, and guiding the course of therapy and medication. Various biomarkers are linked to different cardiovascular conditions. Biomarkers such as natriuretic peptides and troponins are associated with heart failure and acute coronary syndrome respectively. Furthermore, galectin 3 and soluble suppression of tumorigenesis-2 are new biomarkers of cardiovascular diseases. These two biomarkers are also associated with the biomarkers of inflammation, metabolism, and fibrosis. One of the major roles of biomarkers is to identify patients who are at a high risk of developing cardiovascular diseases. They help in the identification of patients who can receive disease-modifying therapies including aggressive blood pressure control, lipid-lowering therapy, and novel agents like sodium-glucose co-transport 2 inhibitors for decreasing the risk of cardiovascular diseases. This book aims to understand the clinical significance of biomarkers in cardiovascular diseases. It is a valuable compilation of topics, ranging from the basic to the most complex advancements in this area of study. This book is appropriate for students seeking detailed information in this area as well as for experts.
